Taylor, R., Najafi, F
While the 20 different Zyn products authorized for marketing and sale in the US received FDA authorization for marketing as a modified risk tobacco product (MRTP) in June 2026, they are only allowed to make the specific claim that, Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis. No other oral nicotine product has been granted an MRTP order
"Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective"
This machine should not be used for large projects or mass-scale production
- Weigh in on circularity in improvements to our business models through our circular supplier criteria assessment
Studies suggest that there are biologic effects of nicotine from e-cigarettes on teenagers who use them, and it may also be harmful to adolescent development